Skip to main content

Table 1 Baseline demographic and clinical characteristics of laboratory confirmed enrolled malaria patients (n = 24)

From: Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India

Gender

 Male

11 (45.83%)

 Female

13 (54.16%)

Age

 Children (1–17 years)

21 (87.5%)

 Adult (18 years and above)

3 (12.5%)

History of malaria and treatment taken

 History of treatment before reporting to study hospital

11 (45.83%)

 History of malaria in last 6 months

2 (8.33%)

Clinical findings

 Palpable splenomegaly

10 (41.66%)

 Palpable hepatomegaly

11 (45.83%)

Malaria diagnosis

 Positive by microscopy

10 (41.7%)

 Positive by both microscopy RDT

9 (37.5%)

 Positive by RDT

5 (20.8%)

Hemoglobin level

 Range of Hb level on day 0

4.9–13.1 g/dl

Severe malaria criteria on day 0

 Severe anemia

8 (33.33%)

 Impaired consciousness

8 (33.33%)

 Respiratory distress- SPO2 < 92% on room air with any signs of respiratory rate > 30/min or presence of crepitations on auscultation

6 (25%)

 Hyperparasitemia

4(16.66%)

 Jaundice- plasma or serum Bilirubin > 3 mg/dl

3 (12.5%)

 Shock with systolic blood pressure < 70 mm Hg in children and < 80 mm Hg in adults

2 (8.33%)

 Multiple convulsions

1 (4.16%)

 Renal impairment—plasma or serum creatinine > 3 mg/dl

1 (4.16%)

 Prostration

1(4.16%)

  1. Figures in parentheses indicate percentage